Back to Search
Start Over
Targeted adjuvant therapy in non-small cell lung cancer : trick or treat?
- Source :
- The European respiratory journal, European Respiratory Journal, 58(4):2101637. European Respiratory Society
- Publication Year :
- 2021
-
Abstract
- Immuno- and targeted therapy improved survival in metastatic NSCLC, but before their implementation in early disease, several challenges need to be overcome. Adequate staging is important, and molecular testing must be incorporated in early disease.https://bit.ly/3heLe6W
- Subjects :
- Pulmonary and Respiratory Medicine
Oncology
OSIMERTINIB
PD-L1
medicine.medical_specialty
Lung Neoplasms
medicine.medical_treatment
EGFR
VINORELBINE
Improved survival
Targeted therapy
Internal medicine
Carcinoma, Non-Small-Cell Lung
Antineoplastic Combined Chemotherapy Protocols
Adjuvant therapy
TYROSINE KINASE INHIBITORS
Medicine
Humans
BENEFIT
IMMUNOTHERAPY
Lung cancer
Pneumonectomy
SURVIVAL ANALYSIS
Neoplasm Staging
business.industry
Early disease
PLUS CISPLATIN
CHEMOTHERAPY
medicine.disease
Combined Modality Therapy
Chemotherapy, Adjuvant
Non small cell
Human medicine
business
Subjects
Details
- Language :
- English
- ISSN :
- 09031936
- Database :
- OpenAIRE
- Journal :
- The European respiratory journal
- Accession number :
- edsair.doi.dedup.....4298d0dd1c5aa114f9297df6951ea756